Cairn Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Hold
17,800
0.71% 35
2025
Q4
$1.52M Hold
17,800
0.72% 35
2025
Q3
$1.38M Hold
17,800
0.63% 38
2025
Q2
$1.39M Buy
17,800
+2,500
+16% +$186K 0.73% 37
2025
Q1
$1.11M Sell
15,300
-900
-6% -$64.4K 0.63% 38
2024
Q4
$1.2M Hold
16,200
0.7% 39
2024
Q3
$1.07M Hold
16,200
0.59% 42
2024
Q2
$1.5M Hold
16,200
0.87% 35
2024
Q1
$1.55M Hold
16,200
0.89% 36
2023
Q4
$1.24M Hold
16,200
0.77% 38
2023
Q3
$1.12M Hold
16,200
0.74% 38
2023
Q2
$1.53M Hold
16,200
0.99% 29
2023
Q1
$1.34M Sell
16,200
-335
-2% -$26.3K 0.93% 33
2022
Q4
$1.23M Buy
16,535
+335
+2% +$25.8K 0.92% 37
2022
Q3
$1.34M Sell
16,200
-1,400
-8% -$135K 1.08% 30
2022
Q2
$1.67M Hold
17,600
1.3% 29
2022
Q1
$2.85M Hold
17,600
1.81% 20
2021
Q4
$2.28M Hold
17,600
1.57% 22
2021
Q3
$1.99M Hold
17,600
1.47% 24
2021
Q2
$1.82M Sell
17,600
-100
-0.6% -$9.43K 1.34% 26
2021
Q1
$1.48M Hold
17,700
1.23% 31
2020
Q4
$1.61M Hold
17,700
1.53% 26
2020
Q3
$1.41M Hold
17,700
1.5% 26
2020
Q2
$1.22M Sell
17,700
-1,200
-6% -$85.3K 1.49% 31
2020
Q1
$1.19M Hold
18,900
1.77% 24
2019
Q4
$1.47M Buy
+18,900
New +$1.48M 1.46% 31

Other funds holding EW

Cairn Investment Group's EW Position: Q1 2026 in Review

Cairn Investment Group held its Edwards Lifesciences (EW) position steady in Q1 2026 at 17,800 shares worth $1.43M. The position accounts for 0.71% of the portfolio, ranked #35.

Cairn Investment Group first reported a position in EW in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.85M in Q1 2022. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Cairn Investment Group held 17,800 shares of Edwards Lifesciences worth $1.43M as of Q1 2026.
  • Cairn Investment Group left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.71% of Cairn Investment Group's portfolio in Q1 2026, its #35 holding.
  • Cairn Investment Group first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 26 quarters since.
  • Cairn Investment Group's Edwards Lifesciences position peaked at $2.85M in Q1 2022.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Cairn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.